title: Clinical significance of low levels of minimal residual disease at the end of remission induction therapy in childhood acute lymphoblastic leukemia.
authors.affiliation: Department of Oncology, St Jude Children's Research Hospital, Memphis, TN 38105, USA.
authors.forename: Patricia
authors.initials: P
authors.lastname: Stow
authors.forename: Laura
authors.initials: L
authors.lastname: Key
authors.forename: Xiaohua
authors.initials: X
authors.lastname: Chen
authors.forename: Qiulu
authors.initials: Q
authors.lastname: Pan
authors.forename: Geoffrey A
authors.initials: GA
authors.lastname: Neale
authors.forename: Elaine
authors.initials: E
authors.lastname: Coustan-Smith
authors.forename: Charles G
authors.initials: CG
authors.lastname: Mullighan
authors.forename: Yinmei
authors.initials: Y
authors.lastname: Zhou
authors.forename: Ching-Hon
authors.initials: CH
authors.lastname: Pui
authors.forename: Dario
authors.initials: D
authors.lastname: Campana
mesh_terms: D000293:Adolescent; D002648:Child; D002675:Child, Preschool; D005260:Female; D006801:Humans; D007223:Infant; D007231:Infant, Newborn; D008297:Male; D018365:Neoplasm, Residual; D054198:Precursor Cell Lymphoblastic Leukemia-Lymphoma / Q000175:diagnosis / Q000517:prevention & control / Q000628:therapy*; D011379:Prognosis; D012008:Recurrence; D012074:Remission Induction; D012189:Retrospective Studies; D012307:Risk Factors; D013997:Time Factors